age ~60
from Lost Creek, WV
Overview: updates on the management of CLL/SLL Prof Stephan Stilgenbau...
"What if the borders between humanity, technology, and nature are only...
Stephan Stilgenbauer, MD, PhD of Ulm University, Ulm, Germany, discuss...
Professor David P. Billington gives a lecture about the exhibition, "T...
Venetoclax is a novel agent in CLL targetting disease biology that is ...
In this video i show you guys the top 5 suspension mods i personally d...